Cargando…

New Insight into Therapies Targeting Angiogenesis in Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is a malignancy characterized by neoangiogenesis that is determined by an augmented production of proangiogenesis factors by tumor and adjacent cells. This unbalanced angiogenesis process is a key feature of HCC carcinogenesis and progression. Proangiogenic factors als...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mossenta, Monica, Busato, Davide, Baboci, Lorena, Di Cintio, Federica, Toffoli, Giuseppe, Dal Bo, Michele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721310/ https://www.ncbi.nlm.nih.gov/pubmed/31370258 http://dx.doi.org/10.3390/cancers11081086

Ejemplares similares

Novel Nanotechnology Approaches to Overcome Drug Resistance in the Treatment of Hepatocellular Carcinoma: Glypican 3 as a Useful Target for Innovative Therapies
por: Mossenta, Monica, et al.
Publicado: (2022)

Glucose Metabolism and Oxidative Stress in Hepatocellular Carcinoma: Role and Possible Implications in Novel Therapeutic Strategies
por: Mossenta, Monica, et al.
Publicado: (2020)

A Novel Epigenetic Machine Learning Model to Define Risk of Progression for Hepatocellular Carcinoma Patients
por: Bedon, Luca, et al.
Publicado: (2021)

The Proteoglycan Glypican-1 as a Possible Candidate for Innovative Targeted Therapeutic Strategies for Pancreatic Ductal Adenocarcinoma
por: Busato, Davide, et al.
Publicado: (2022)

The Molecular and Microenvironmental Landscape of Glioblastomas: Implications for the Novel Treatment Choices
por: Di Cintio, Federica, et al.
Publicado: (2020)

The Dual Role of the Liver in Nanomedicine as an Actor in the Elimination of Nanostructures or a Therapeutic Target
por: Baboci, Lorena, et al.
Publicado: (2020)

A Pan-Cancer Approach to Predict Responsiveness to Immune Checkpoint Inhibitors by Machine Learning
por: Polano, Maurizio, et al.
Publicado: (2019)

A novel complement-fixing IgM antibody targeting GPC1 as a useful immunotherapeutic strategy for the treatment of pancreatic ductal adenocarcinoma
por: Busato, Davide, et al.
Publicado: (2023)

Role of Virus-Related Chronic Inflammation and Mechanisms of Cancer Immune-Suppression in Pathogenesis and Progression of Hepatocellular Carcinoma
por: Borgia, Melissa, et al.
Publicado: (2021)

A New Epigenetic Model to Stratify Glioma Patients According to Their Immunosuppressive State
por: Polano, Maurizio, et al.
Publicado: (2021)

Machine learning to improve interpretability of clinical, radiological and panel-based genomic data of glioma grade 4 patients undergoing surgical resection
por: Dal Bo, Michele, et al.
Publicado: (2023)

Targeting Angiogenesis for Advanced Hepatocellular Carcinoma
por: Eso, Yuji
Publicado: (2020)

Angiogenesis in Hepatocellular Carcinoma; Pathophysiology, Targeted Therapy, and Role of Imaging
por: Moawad, Ahmed W, et al.
Publicado: (2020)

Targeted chitosan nanobubbles as a strategy to down-regulate microRNA-17 into B-cell lymphoma models
por: Capolla, Sara, et al.
Publicado: (2023)

Angiogenesis Inhibitors for the Treatment of Hepatocellular Carcinoma
por: Berretta, Massimiliano, et al.
Publicado: (2016)

A comprehensive overview on antibody-drug conjugates: from the conceptualization to cancer therapy
por: Riccardi, Federico, et al.
Publicado: (2023)

Adipose mesenchymal stromal/stem cells expanded by a GMP compatible protocol displayed improved adhesion on cancer cells in flow conditions
por: Agostini, Francesco, et al.
Publicado: (2020)

Immune Checkpoint Inhibitors as Monotherapy or Within a Combinatorial Strategy in Advanced Hepatocellular Carcinoma
por: Guardascione, Michela, et al.
Publicado: (2020)

Loss of Spry1 reduces growth of BRAF(V600)-mutant cutaneous melanoma and improves response to targeted therapy
por: Montico, Barbara, et al.
Publicado: (2020)

Angiogenesis in hepatocellular carcinoma: mechanisms and anti-angiogenic therapies
por: Yao, Changyu, et al.
Publicado: (2023)

Pharmacological strategies to prevent SARS-CoV-2 infection and treat the early phases of COVID-19
por: Scarabel, Lucia, et al.
Publicado: (2021)

Thermoresponsive Chitosan-Grafted-Poly(N-vinylcaprolactam) Microgels via Ionotropic Gelation for Oncological Applications
por: Marsili, Lorenzo, et al.
Publicado: (2021)

Chitosan-Based Biocompatible Copolymers for Thermoresponsive Drug Delivery Systems: On the Development of a Standardization System
por: Marsili, Lorenzo, et al.
Publicado: (2021)

Angiogenesis of hepatocellular carcinoma: An immunohistochemistry study
por: Fodor, Decebal, et al.
Publicado: (2019)

Pharmacogenetics of the systemic treatment in advanced hepatocellular carcinoma
por: De Mattia, Elena, et al.
Publicado: (2019)

Nogo‐B promotes tumor angiogenesis and provides a potential therapeutic target in hepatocellular carcinoma
por: Cai, Hao, et al.
Publicado: (2018)

Angiogenesis and Hepatocellular Carcinoma: From Molecular Mechanisms to Systemic Therapies
por: Pinto, Elisa, et al.
Publicado: (2023)

Nanoparticles-Based Oligonucleotides Delivery in Cancer: Role of Zebrafish as Animal Model
por: Bozzer, Sara, et al.
Publicado: (2021)

Downregulation of miRNA-638 promotes angiogenesis and growth of hepatocellular carcinoma by targeting VEGF
por: Cheng, Jiwen, et al.
Publicado: (2016)

Deguelin suppresses angiogenesis in human hepatocellular carcinoma by targeting HGF-c-Met pathway
por: Li, Ming, et al.
Publicado: (2017)

Anti-Hepatocellular Carcinoma Biomolecules: Molecular Targets Insights
por: Juaid, Nouf, et al.
Publicado: (2021)

Nanocarriers as a Delivery Platform for Anticancer Treatment: Biological Limits and Perspectives in B-Cell Malignancies
por: Bozzer, Sara, et al.
Publicado: (2022)

Angiogenesis: From Chronic Liver Inflammation to Hepatocellular Carcinoma
por: Sanz-Cameno, Paloma, et al.
Publicado: (2010)

Hypoxia-inducible factor 1, hepatocellular carcinoma and angiogenesis
por: Kim, Jin-Wook
Publicado: (2010)

Fucoidan Inhibits the Growth of Hepatocellular Carcinoma Independent of Angiogenesis
por: Zhu, Cong, et al.
Publicado: (2013)

NDRG2 inhibition facilitates angiogenesis of hepatocellular carcinoma
por: Wang, Jianlong, et al.
Publicado: (2021)

The perplexity of targeting genetic alterations in hepatocellular carcinoma
por: Barone, Michele, et al.
Publicado: (2020)

Circulating-Free DNA Analysis in Hepatocellular Carcinoma: A Promising Strategy to Improve Patients’ Management and Therapy Outcomes
por: Mezzalira, Silvia, et al.
Publicado: (2019)

Hypoxia-inducible MiR-182 promotes angiogenesis by targeting RASA1 in hepatocellular carcinoma
por: Du, Chengli, et al.
Publicado: (2015)

Exosomal MiR-1290 Promotes Angiogenesis of Hepatocellular Carcinoma via Targeting SMEK1
por: Wang, Qiong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_k08853skkncidm8ehr1vmv8vc4